摘要
研究了中药脂血康煎剂对冠心病102例的血浆脂蛋白、载脂蛋白(Apo)、高密度脂蛋白(HDL)亚组分HDL2、HDL3水平的影响,并通过4%~30%聚丙烯酰胺梯度凝胶电泳观察了给药前后HDL亚组分的颗粒直径和相对百分含量的变化。结果显示,脂血康能显著降低患者血浆甘油三酯(TG,P<0.05),总胆固醇(Tc,P<0.05),低密度脂蛋白胆固醇(LDLc,P<0.05)和ApoB(P<0.02)的水平以及冠脉风险指数(CI,P<0.005),升高ApoA-Ⅰ(P<0.005)、HDLc(P<0.01)和HDL2c(P<0.005)的水平,增加颗粒直径较大的HDL2b的相对百分含量(P<0.05),而且作用优于复方丹参片。提示脂血康能有效地改善冠心病患者的脂蛋白代谢,影响HDL的化学组成和颗粒分布,促进胆固醇逆向转运,从而预防动脉粥样硬化病变的发展。
One hundred and two patients with coronary heart disease(CHD) were treated by ZXK in 8 weeks, the levels of plasma lipoproteins, apolipoproteins and HDL subfractions HDL2cand HDL3c were measured , the particles size of HDL subclasses and the ratio of each in whole HDL was analysed by 4% to 30% polyacrylamide gradient gel electrophoresis. It has shown that the concentrations of TG (P<0. 05 ) , Tc (P<0. 05 ), LDLc (P<0. 05)and ApoB(P<0. 02)were lower, while the levels of ApoA-I (P<0. 005 ) ,HDLc(P<0. 01 ), HDL2c(P<0. 005 ) were higher significantly after ZXK administration than before. The ratio of larger particle subclass HDL2b increased (P<0. 05). The ZXK can improve CHD patients' lipoproteins metabolism, alter HDL composition and subclasses distribution to increase the ability of reverse cholesterol transport and prevent the development of atherosclerotic lesions.
出处
《山东医科大学学报》
1996年第4期283-286,共4页
Acta Academiae Medicinae Shandong
基金
山东省教委科研基金
关键词
脂血康
冠心病
脂蛋白
高密度脂蛋白
亚组分
Zhixuekang
Coronary disease
Lipoproteins. HDL
Lipoproteins subfractions
Electrophoresis, polyacrylamide gel